USD 3.63
(-6.2%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 28.25 Million USD | 14.0% |
2022 | 24.78 Million USD | -0.96% |
2021 | 25.02 Million USD | -9.99% |
2020 | 27.79 Million USD | 21.3% |
2019 | 22.91 Million USD | 72.04% |
2018 | 13.32 Million USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 26.88 Million USD | -2.93% |
2024 Q1 | 27.69 Million USD | -1.98% |
2023 Q4 | 28.25 Million USD | 1.25% |
2023 Q3 | 27.9 Million USD | 10.02% |
2023 FY | 28.25 Million USD | 14.0% |
2023 Q2 | 25.36 Million USD | -0.69% |
2023 Q1 | 25.53 Million USD | 3.05% |
2022 FY | 24.78 Million USD | -0.96% |
2022 Q4 | 24.78 Million USD | 0.41% |
2022 Q2 | 23.23 Million USD | 2.19% |
2022 Q3 | 24.68 Million USD | 6.23% |
2022 Q1 | 22.73 Million USD | -9.13% |
2021 Q4 | 25.02 Million USD | -15.17% |
2021 FY | 25.02 Million USD | -9.99% |
2021 Q1 | 29.72 Million USD | 6.91% |
2021 Q2 | 28.1 Million USD | -5.43% |
2021 Q3 | 29.49 Million USD | 4.94% |
2020 Q3 | 29.88 Million USD | 4.62% |
2020 FY | 27.79 Million USD | 21.3% |
2020 Q4 | 27.79 Million USD | -6.97% |
2020 Q2 | 28.56 Million USD | 8.04% |
2020 Q1 | 26.43 Million USD | 15.35% |
2019 FY | 22.91 Million USD | 72.04% |
2019 Q4 | 22.91 Million USD | 13.55% |
2019 Q3 | 20.18 Million USD | 7.84% |
2019 Q2 | 18.71 Million USD | 4.15% |
2019 Q1 | 17.97 Million USD | 34.91% |
2018 FY | 13.32 Million USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q4 | 13.32 Million USD | 0.0% |
2018 Q2 | - USD | 100.0% |
2018 Q1 | -318.99 Thousand USD | 0.0% |
2017 Q1 | 393.52 Thousand USD | 0.0% |
2017 Q2 | 316.46 Thousand USD | -19.58% |
2017 Q3 | 242.3 Thousand USD | -23.43% |
2017 Q4 | - USD | -100.0% |
2017 FY | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Cosmos Health Inc. | 4.78 Million USD | -489.949% |
Safety Shot Inc | 1.86 Million USD | -1411.141% |
Bright Green Corporation | - USD | -Infinity% |
Embecta Corp. | 152.1 Million USD | 81.425% |
ANI Pharmaceuticals, Inc. | 111.19 Million USD | 74.592% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | -317.388% |
Collegium Pharmaceutical, Inc. | 32.33 Million USD | 12.616% |
Dynavax Technologies Corporation | 53.29 Million USD | 46.983% |
Esperion Therapeutics, Inc. | 65.62 Million USD | 56.946% |
Intra-Cellular Therapies, Inc. | 11.64 Million USD | -142.577% |
Pacira BioSciences, Inc. | 104.35 Million USD | 72.926% |
PainReform Ltd. | - USD | -Infinity% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -392.663% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -392.663% |
SCYNEXIS, Inc. | - USD | -Infinity% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -3389.071% |
Journey Medical Corporation | 10.2 Million USD | -176.827% |
Alpha Teknova, Inc. | 11.59 Million USD | -143.686% |
Procaps Group, S.A. | 96.83 Million USD | 70.823% |
Theratechnologies Inc. | 6.06 Million USD | -365.76% |
Harrow Health, Inc. | 10.86 Million USD | -159.989% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -939.095% |
Biofrontera Inc. | 10.9 Million USD | -159.012% |
DURECT Corporation | 2.21 Million USD | -1173.231% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 63.501% |
Cronos Group Inc. | 30.33 Million USD | 6.876% |
OptiNose, Inc. | 8.05 Million USD | -250.882% |
Ironwood Pharmaceuticals, Inc. | 1.00 USD | -2825299900.0% |
Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
RedHill Biopharma Ltd. | 5.69 Million USD | -395.751% |
Guardion Health Sciences, Inc. | 2.67 Million USD | -955.354% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -512.948% |
Radius Health, Inc. | 278.64 Million USD | 89.86% |
Universe Pharmaceuticals INC | 3.34 Million USD | -745.072% |
ProPhase Labs, Inc. | 3.84 Million USD | -635.564% |
Phibro Animal Health Corporation | 265.91 Million USD | 89.375% |
Procaps Group S.A. | 96.83 Million USD | 70.823% |
Alvotech | 74.43 Million USD | 62.042% |
TherapeuticsMD, Inc. | - USD | -Infinity% |
Viatris Inc. | 3.46 Billion USD | 99.186% |
Rockwell Medical, Inc. | 5.87 Million USD | -381.23% |
Aytu BioPharma, Inc. | 12.63 Million USD | -123.644% |
SIGA Technologies, Inc. | 64.21 Million USD | 56.005% |
Tilray Brands, Inc. | 252.08 Million USD | 88.792% |
Lifecore Biomedical, Inc. | 39.97 Million USD | 29.33% |
Shineco, Inc. | 1.58 Million USD | -1678.568% |
PetIQ, Inc. | 159.3 Million USD | 82.265% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 18592.846% |
Incannex Healthcare Limited | -10.01 Million USD | 382.107% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | 26.232% |
Alimera Sciences, Inc. | 1.87 Million USD | -1403.619% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 37.68 Million USD | 25.031% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | -1654.419% |
Clever Leaves Holdings Inc. | 4.48 Million USD | -530.225% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -11007.835% |
Avadel Pharmaceuticals plc | 10.38 Million USD | -172.187% |
Hempacco Co., Inc. | 2.54 Million USD | -1011.173% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 74.43 Million USD | 62.042% |
Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 40.886% |
Lantheus Holdings, Inc. | 64.02 Million USD | 55.875% |
Currenc Group, Inc. | 732.91 Thousand USD | -3754.902% |
Kamada Ltd. | 87.74 Million USD | 67.802% |
Indivior PLC | 141.79 Million USD | 80.075% |
Evoke Pharma, Inc. | 481.84 Thousand USD | -5763.565% |
Flora Growth Corp. | 8.5 Million USD | -232.076% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -11007.835% |
Evolus, Inc. | 10.99 Million USD | -156.892% |
HUTCHMED (China) Limited | 50.25 Million USD | 43.784% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 73.304% |
Akanda Corp. | 1.28 Million USD | -2095.441% |